OUTCOME OF CHILDREN TREATED FOR RECURRENT EPSTEIN-BARR VIRUS (EBV)-ASSOCIATED POST-TRANSPLANT LYMPHOPROLIFERATIVE DISEASE (PTLD). (October 2022)